Intratympanic gentamicin treatment in Meniere's disease: Patients' experiences and outcomes

Journal of Laryngology and Otology

Volumn 120, Issue 9, 2006, Pages 730-735

  Smith, W K ^a   Sandooram, D ^b   Prinsley, P R ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b Worthing Hospital   (United Kingdom)

^c JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Gentamicin; M ni re's Disease; Otologic Surgical Procedures; Quality of Life

Indexed keywords

BETAHISTINE; CINNARIZINE; GENTAMICIN; PROCHLORPERAZINE;

ACUPUNCTURE; ADULT; AGED; AUDIOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; FEMALE; FOLLOW UP; GLASGOW OUTCOME SCALE; HEALTH SURVEY; HEARING DISORDER; HEARING LOSS; HUMAN; MALE; MEDICAL RECORD; MENIERE DISEASE; PATIENT CARE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; TINNITUS; TREATMENT OUTCOME; TYMPANOSTOMY TUBE; UNSTEADINESS; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; FEMALE; GENTAMICINS; HEALTH STATUS INDICATORS; HEARING LOSS, SENSORINEURAL; HUMANS; INJECTIONS; MALE; MENIERE DISEASE; MENIERE'S DISEASE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; TYMPANIC MEMBRANE; VERTIGO;

EID: 33748948931     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022215106002283     Document Type: Review

References (25)

1. Beck C, Schmidt CL. Ten years experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 1978;221:149-52
2. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998;19:435-42
3. Pfleiderer AG. The current role of local intratympanic gentamicin therapy in the management of unilateral Meniere's disease. Clin Otolaryngol 1998;23:34-41
4. Yardley L, Masson E, Verschuur C, Haacke N, Luxon L. Symptoms, anxiety and handicap in dizzy patients: development of the Vertigo Symptom Scale. J Psychosom Res 1992;36:731-41
5. Robinson K, Gatehouse S, Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhino Laryngol 1996;105:415-22
6. Sandooram D, Grunfeld EA, McKinney C, Gleeson MJ. Should we be managing more vestibular schwannoma patients conservatively? In: Proceedings of the 4th International Conference on Vestibular Schwannoma and Other CPA Lesions, July 2003, 2003;144-5
7. Furstenberg AC, Lashmet FH, Lathrop F. Meniere's syndrome complex: medical treatment. Ann Otol Rhinol Laryngol 1984;43:1035-46
8. Van Deelen GW, Huizing EH. Use of diuretic Dyazide in the treatment of Meniere's disease. A double-blind cross-over placebo-controlled study. ORL J Otorhinolaryngol Relat Spec 1986;48:287-92
9. Weintraub S, Arenberg IK, Spector GJ, Stroud MH. The efficacy of "conservative" medical regimens on the rate of hearing losses in Meniere's syndrome: a retrospective computerized statistical analysis. Laryngoscope 1976;86:1391-6
10. Santos PM, Hall RA, Snyder JM, Hughes LF. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on Hearing and Equilibrium Guidelines. Otolaryngol Head Neck Surg 1993;109:680-9
11. James A, Burton M. Betahistine for Meniere's disease or syndrome. Cochrane Systematic Review Database 2001;1: CD001873
12. Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989;100:6-16
13. Silverstein H, Norrell H, Rosenberg S. The resurrection of vestibular neurectomy: a 10 year experience with 115 cases. J Neurosurg 1990;72:533-9
14. Snow JB, Kimmelman CP. Assessment of surgical procedures for Meniere's disease. Laryngoscope 1979;89:737-747
15. Odkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallqvist J. Effects of middle ear pressure changes on clinical symptoms in patients with Meniere's disease - a clinical multicentre placebo-controlled study. Acta Otolaryngol Suppl 2000;543:99-101
16. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997;221:149-52
17. Soderman AC, Bergenius J, Bagger-Sjoback D, Tjell C, Langius A. Patient's subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence and treatment in Meniere's disease. Otol Neurotol 2001;22:526-33
18. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 2000;110:1298-305
19. Abou-Halawa AS, Peo DS. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Meniere's disease. Otol Neurotol 2002;23:494-502
20. Walsted A. Unpredictable hearing loss after intratympanic gentamicin treatment for vertigo: a new theory. Acta Otolaryngol 2001;121:42-4
21. Becarovski Z, Bojrab DI, Michaelides EM, Kartush JM, Zappia JJ, La Rouere MJ. Round window gentamicin absorption: an in vivo human model. Laryngoscope 2002;112:1610-13
22. Pandya A, Xia X, Radnaabazar J, Batsuuri J, Dangaansuren B, Fiscjel-Godsian N et al. Mutation in the mitochondrial 12S r RNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J Med Genet 1997;34:169-72
23. Yetiser S, Kertmen M. Intratympanic gentamicin in Meniere's disease: the impact on tinnitus. Int J Audiol 2002;41:363-70
24. Kaasinen S, Puukko I, Ishizaki H, Aalto H. Intratympanic gentamicin in Meniere's disease. Acta Otolaryngol 1998;118:294-8
25. De Waele C, Megienni R, Freyss G, Zamith F, Bellalimat N, Vidai PP et al. Intratympanic gentamicin injections for Meniere's disease: vestibular hair cell impairment and regeneration. Neurology 2002;59:1442-4